Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

NIH grant to support Alexion's 5G1.1 in lupus trials

March 10, 2000

Taisho presents new interleukin production inhibitors with nitroaniline structure

March 9, 2000

InKine initiates pharmacokinetic study of tablet formulation of CBP-1011

March 9, 2000

Merck patents new series of cytokine inhibitors with imidazole structure

March 1, 2000

Valdecoxib: profile of an up-and-coming COX-2 inhibitor

Feb. 28, 2000

Remicade recommended for approval in E.U. for treatment of rheumatoid arthritis

Feb. 24, 2000

Novel class of antiinflammatory therapeutics emerges from R&D at Centaur

Feb. 21, 2000

Phosphinic/phosphonic acids as MMP inhibitors

Feb. 21, 2000

Eos and collaborators identify novel genes involved in immune system regulation

Feb. 21, 2000

Production, synthesis and activity of new Xenova compounds for immunoinflammatory conditions

Feb. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.